Quantitative assessment of dyskinesias in subhuman primates
Identifieur interne :
002D23 ( PascalFrancis/Corpus );
précédent :
002D22;
suivant :
002D24
Quantitative assessment of dyskinesias in subhuman primates
Auteurs : J. M. Brotchie ;
S. H. FoxSource :
-
Movement disorders [ 0885-3185 ] ; 1999.
RBID : Pascal:99-0505699
Descripteurs français
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 14 |
---|
A06 | | | | @3 SUP1 |
---|
A08 | 01 | 1 | ENG | @1 Quantitative assessment of dyskinesias in subhuman primates |
---|
A09 | 01 | 1 | ENG | @1 Dyskinesias |
---|
A11 | 01 | 1 | | @1 BROTCHIE (J. M.) |
---|
A11 | 02 | 1 | | @1 FOX (S. H.) |
---|
A14 | 01 | | | @1 Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester @2 Manchester @3 GBR @Z 1 aut. @Z 2 aut. |
---|
A18 | 01 | 1 | | @1 Toulouse Clinical Investigation Centre @3 FRA @9 patr. |
---|
A20 | | | | @1 40-47 |
---|
A21 | | | | @1 1999 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000089920840060 |
---|
A44 | | | | @0 0000 @1 © 1999 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 46 ref. |
---|
A47 | 01 | 1 | | @0 99-0505699 |
---|
A60 | | | | @1 P @2 C |
---|
A61 | | | | @0 A |
---|
A64 | 01 | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B02U01 |
---|
C03 | 01 | X | FRE | @0 Dyskinésie @5 01 |
---|
C03 | 01 | X | ENG | @0 Dyskinesia @5 01 |
---|
C03 | 01 | X | SPA | @0 Disquinesia @5 01 |
---|
C03 | 02 | X | FRE | @0 Lévodopa @5 04 |
---|
C03 | 02 | X | ENG | @0 Levodopa @5 04 |
---|
C03 | 02 | X | SPA | @0 Levodopa @5 04 |
---|
C03 | 03 | X | FRE | @0 Antiparkinsonien @5 05 |
---|
C03 | 03 | X | ENG | @0 Antiparkinson agent @5 05 |
---|
C03 | 03 | X | SPA | @0 Antiparkinsoniano @5 05 |
---|
C03 | 04 | X | FRE | @0 Echelle mesure @5 07 |
---|
C03 | 04 | X | ENG | @0 Measurement scale @5 07 |
---|
C03 | 04 | X | SPA | @0 Escala medida @5 07 |
---|
C03 | 05 | X | FRE | @0 Article synthèse @5 16 |
---|
C03 | 05 | X | ENG | @0 Review @5 16 |
---|
C03 | 05 | X | SPA | @0 Artículo síntesis @5 16 |
---|
C03 | 06 | X | FRE | @0 Exploration @5 17 |
---|
C03 | 06 | X | ENG | @0 Exploration @5 17 |
---|
C03 | 06 | X | SPA | @0 Exploración @5 17 |
---|
C03 | 07 | X | FRE | @0 Toxicité @5 18 |
---|
C03 | 07 | X | ENG | @0 Toxicity @5 18 |
---|
C03 | 07 | X | SPA | @0 Toxicidad @5 18 |
---|
C03 | 08 | X | FRE | @0 Animal @5 20 |
---|
C03 | 08 | X | ENG | @0 Animal @5 20 |
---|
C03 | 08 | X | SPA | @0 Animal @5 20 |
---|
C03 | 09 | X | FRE | @0 Singe @5 21 |
---|
C03 | 09 | X | ENG | @0 Monkey @5 21 |
---|
C03 | 09 | X | SPA | @0 Mono @5 21 |
---|
C07 | 01 | X | FRE | @0 Primates @2 NS |
---|
C07 | 01 | X | ENG | @0 Primates @2 NS |
---|
C07 | 01 | X | SPA | @0 Primates @2 NS |
---|
C07 | 02 | X | FRE | @0 Mammalia @2 NS |
---|
C07 | 02 | X | ENG | @0 Mammalia @2 NS |
---|
C07 | 02 | X | SPA | @0 Mammalia @2 NS |
---|
C07 | 03 | X | FRE | @0 Vertebrata @2 NS |
---|
C07 | 03 | X | ENG | @0 Vertebrata @2 NS |
---|
C07 | 03 | X | SPA | @0 Vertebrata @2 NS |
---|
C07 | 04 | X | FRE | @0 Système nerveux pathologie @5 37 |
---|
C07 | 04 | X | ENG | @0 Nervous system diseases @5 37 |
---|
C07 | 04 | X | SPA | @0 Sistema nervioso patología @5 37 |
---|
C07 | 05 | X | FRE | @0 Trouble neurologique @5 38 |
---|
C07 | 05 | X | ENG | @0 Neurological disorder @5 38 |
---|
C07 | 05 | X | SPA | @0 Trastorno neurológico @5 38 |
---|
C07 | 06 | X | FRE | @0 Mouvement involontaire @5 39 |
---|
C07 | 06 | X | ENG | @0 Involuntary movement @5 39 |
---|
C07 | 06 | X | SPA | @0 Movimiento involuntario @5 39 |
---|
C07 | 07 | X | FRE | @0 Extrapyramidal syndrome @5 40 |
---|
C07 | 07 | X | ENG | @0 Extrapyramidal syndrome @5 40 |
---|
C07 | 07 | X | SPA | @0 Extrapiramidal síndrome @5 40 |
---|
N21 | | | | @1 326 |
---|
|
pR |
A30 | 01 | 1 | ENG | @1 Workshop on L-dopa-induced dyskinesias @3 Toulouse FRA @4 1998-06-03 |
---|
|
Format Inist (serveur)
NO : | PASCAL 99-0505699 INIST |
ET : | Quantitative assessment of dyskinesias in subhuman primates |
AU : | BROTCHIE (J. M.); FOX (S. H.) |
AF : | Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester/Manchester/Royaume-Uni (1 aut., 2 aut.) |
DT : | Publication en série; Congrès; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1999; Vol. 14; No. SUP1; Pp. 40-47; Bibl. 46 ref. |
LA : | Anglais |
CC : | 002B02U01 |
FD : | Dyskinésie; Lévodopa; Antiparkinsonien; Echelle mesure; Article synthèse; Exploration; Toxicité; Animal; Singe |
FG : | Primates; Mammalia; Vertebrata; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome |
ED : | Dyskinesia; Levodopa; Antiparkinson agent; Measurement scale; Review; Exploration; Toxicity; Animal; Monkey |
EG : | Primates; Mammalia; Vertebrata; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome |
SD : | Disquinesia; Levodopa; Antiparkinsoniano; Escala medida; Artículo síntesis; Exploración; Toxicidad; Animal; Mono |
LO : | INIST-20953.354000089920840060 |
ID : | 99-0505699 |
Links to Exploration step
Pascal:99-0505699
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Quantitative assessment of dyskinesias in subhuman primates</title>
<author><name sortKey="Brotchie, J M" sort="Brotchie, J M" uniqKey="Brotchie J" first="J. M." last="Brotchie">J. M. Brotchie</name>
<affiliation><inist:fA14 i1="01"><s1>Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fox, S H" sort="Fox, S H" uniqKey="Fox S" first="S. H." last="Fox">S. H. Fox</name>
<affiliation><inist:fA14 i1="01"><s1>Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0505699</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0505699 INIST</idno>
<idno type="RBID">Pascal:99-0505699</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002D23</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Quantitative assessment of dyskinesias in subhuman primates</title>
<author><name sortKey="Brotchie, J M" sort="Brotchie, J M" uniqKey="Brotchie J" first="J. M." last="Brotchie">J. M. Brotchie</name>
<affiliation><inist:fA14 i1="01"><s1>Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fox, S H" sort="Fox, S H" uniqKey="Fox S" first="S. H." last="Fox">S. H. Fox</name>
<affiliation><inist:fA14 i1="01"><s1>Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term>
<term>Antiparkinson agent</term>
<term>Dyskinesia</term>
<term>Exploration</term>
<term>Levodopa</term>
<term>Measurement scale</term>
<term>Monkey</term>
<term>Review</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dyskinésie</term>
<term>Lévodopa</term>
<term>Antiparkinsonien</term>
<term>Echelle mesure</term>
<term>Article synthèse</term>
<term>Exploration</term>
<term>Toxicité</term>
<term>Animal</term>
<term>Singe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA06><s3>SUP1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Quantitative assessment of dyskinesias in subhuman primates</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Dyskinesias</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>BROTCHIE (J. M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FOX (S. H.)</s1>
</fA11>
<fA14 i1="01"><s1>Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA18 i1="01" i2="1"><s1>Toulouse Clinical Investigation Centre</s1>
<s3>FRA</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>40-47</s1>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000089920840060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>46 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0505699</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02U01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Dyskinésie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dyskinesia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Disquinesia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lévodopa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Levodopa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Levodopa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Echelle mesure</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Measurement scale</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Escala medida</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Article synthèse</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Review</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Artículo síntesis</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Exploración</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Singe</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Monkey</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Mono</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fN21><s1>326</s1>
</fN21>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Workshop on L-dopa-induced dyskinesias</s1>
<s3>Toulouse FRA</s3>
<s4>1998-06-03</s4>
</fA30>
</pR>
</standard>
<server><NO>PASCAL 99-0505699 INIST</NO>
<ET>Quantitative assessment of dyskinesias in subhuman primates</ET>
<AU>BROTCHIE (J. M.); FOX (S. H.)</AU>
<AF>Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester/Manchester/Royaume-Uni (1 aut., 2 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1999; Vol. 14; No. SUP1; Pp. 40-47; Bibl. 46 ref.</SO>
<LA>Anglais</LA>
<CC>002B02U01</CC>
<FD>Dyskinésie; Lévodopa; Antiparkinsonien; Echelle mesure; Article synthèse; Exploration; Toxicité; Animal; Singe</FD>
<FG>Primates; Mammalia; Vertebrata; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome</FG>
<ED>Dyskinesia; Levodopa; Antiparkinson agent; Measurement scale; Review; Exploration; Toxicity; Animal; Monkey</ED>
<EG>Primates; Mammalia; Vertebrata; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome</EG>
<SD>Disquinesia; Levodopa; Antiparkinsoniano; Escala medida; Artículo síntesis; Exploración; Toxicidad; Animal; Mono</SD>
<LO>INIST-20953.354000089920840060</LO>
<ID>99-0505699</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002D23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:99-0505699
|texte= Quantitative assessment of dyskinesias in subhuman primates
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | ![](Common/icons/LogoDilib.gif) |